Yang Fan, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC (NCT07086326) | Yang Fan, MD | 2025-07-31 |
Track Yang Fan, MD automatically
Every clearance here is in the API, with alerts when new ones post.